Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Cracking the Code of Uncontrolled Hypertension
Author(s): Thomas Weber , Bryan Williams , , et al Added: 8 months ago
If you missed the Symposium 'Cracking the Code of Uncontrolled Hypertension' at ESC 2024, the on-demand session is now available.Join Prof Thomas Weber (Klinikum Wels-Grieskirchen, Wels, AT), Prof John Flack (Southern Illinois University School of Medicine, Springfield, US), Prof Alta Schutte (University of New South Wales, Sydney, AU), and Prof Bryan Williams (University College London, London,… View more

Prevention & Chronic Conditions
ACC 25 Late-Breaking Discussion: The ADVANCE-HTN Trial
Author(s): Harriette Van Spall , Luke Laffin Added: 1 month ago
ACC 25 - ADVANCE-HTN shows lorundrostat, an aldosterone synthase inhibitor, effectively lowered 24-hour blood pressure in patients with uncontrolled and true resistant hypertension.Late-breaker discussion host, Dr Harriette Van Spall (McMaster University, Hamilton, CA) is joined by Dr Luke Laffin (Cleveland Clinic, Cleveland, OH, US) to discuss the key findings from the ADVANCE-HTN trial… View more

Prevention & Chronic Conditions
Unlocking the Challenges of Uncontrolled Hypertension
Author(s): Thomas Weber , Erika SW Jones , Bryan Williams Added: 10 months ago
The long term clinical implications of uncontrolled hypertension are well documented, but almost half of those with hypertension remain inadequately treated. In this symposium, our panel of three leading hypertension experts, Prof Thomas Weber (Klinikum Wels-Grieskirchen, Wels, AT), Prof Bryan Williams (University College London, London, UK) and Prof Erika Jones (University of Cape Town, Cape… View more

Prevention & Chronic Conditions
Cracking the Code of Uncontrolled Hypertension
Start date: Aug 30, 2024 End date: Aug 30, 2024
Radcliffe Medical Education is hosting a Satellite Symposium entitled 'Cracking the Code of Uncontrolled Hypertension' at ESC 2024, in London. Join us in the Prague room on Friday 30 August 2024 at 15:15.Add to your calendarOverviewThis symposium will delve into the complexities of uncontrolled hypertension, exploring its clinical impact, treatment barriers, and underlying drivers. It will… View more

Prevention & Chronic Conditions
TCT 23: PICSO-AMI-I: Pressure Controlled Intermittent Coronary Sinus Occlusion in Acute Myocardial Infarction.
Author(s): Giovanni Luigi Di Maria Added: 1 year ago
TCT 23 - We are joined by Dr Giovanni Luigi Di Maria (John Radcliffe Hospital, UK) to discuss the findings of the PICSO-AMI-I study (NCT04958421), sponsored by Miracor Medical. The PICSO-AMI-I study aimed to assess the safety and feasibility of pressure-controlled intermittent coronary sinus occlusion (PiCSO) in patients with ST-elevation myocardial infarction (MI), presenting with TIMI 0 or 1… View more

Intervention
ACC.24: Restrictive Vs Liberal Blood Transfusion in MI Patients: MINT
Author(s): Andrew P DeFillipis Added: 1 year ago
ACC.24 — Dr Andrew P DeFilipis (Vanderbilt University Medical Center, US) joins us onsite at ACC to discuss the findings from a subgroup analysis of the MINT Trial (NCT02981407).MINT is a randomised parallel assignment trial which aims to compare liberal and restrictive blood cell transfusion strategies in patients who have had an acute myocardial infarction (AMI) and are anaemic. Findings were… View more

Heart Failure

MI/ACS
Resistant Hypertension: An Overview
Author(s): Giacomo Buso , Claudia Agabiti-Rosei , Matteo Lemoli , et al Added: 11 months ago

Prevention & Chronic Conditions
CardioNerds @AHA23: KARDIA-1: ALN-AGT01 in Patients With Mild-to Moderate Hypertension
Author(s): George L Bakris , Sukriti Banthiya Added: 1 year ago
AHA 2023 — Investigator, Dr George Bakris (UChicago Medicine, US) is interviewed by Dr Sukriti Banthiya, CardioNerds Ambassador on the new findings of KARDIA-1 trial (NCT04936035).This randomized, double-blind, placebo-controlled, dose-ranging multicenter study (Alnylam Pharmaceuticals) aimed to evaluate the effect of ALN-AGT01 (zilbesiran) on systolic and diastolic blood pressure in patients… View more

Prevention & Chronic Conditions
AHA 23: 3 Trials That Will Change My Practice
Author(s): Purvi Parwani Added: 1 year ago
AHA 23 — Dr Purvi Parwani, cardiologist and multimodality imager, and director of the Women's Heart Clinic at Loma Linda University Health in the US, spotlights three game-changing late-breaking science trials from the AHA Scientific Sessions. Discover the trials anticipated to reshape clinical practices as Dr Parwani shares her insights.Trials discussed in detail include:POP-HT: Cardiac… View more

Guidelines & Statements

Prevention & Chronic Conditions
Job title: Emeritus Professor of Medicine